The syndrome of rhabdomyolysis: Pathophysiology and diagnosis

European Journal of Internal Medicine

Volumn 18, Issue 2, 2007, Pages 90-100

  Giannoglou, George D ^a   Chatzizisis, Yiannis S ^a   Misirli, Gesthimani ^a  

^a AHEPA UNIVERSITY HOSPITAL   (Greece)

Author keywords

Calcium; Cell death; Diagnosis; Energy depletion; Rhabdomyolysis

Indexed keywords

CALCIUM; CREATINE KINASE; CREATININE; MYOGLOBIN; PROTEINASE; UREA;

CELL DAMAGE; CELL DEATH; CELL ENERGY; CELL MEMBRANE; CIRCULATION; CLINICAL FEATURE; ENERGY TRANSFER; ENZYME ACTIVATION; HUMAN; HYPERKALEMIA; HYPERURICEMIA; METABOLIC ACIDOSIS; MITOCHONDRION; MUSCLE CELL; MUSCLE WEAKNESS; MYALGIA; MYOGLOBINURIA; OXIDATIVE STRESS; PATHOPHYSIOLOGY; REVIEW; RHABDOMYOLYSIS; SKELETAL MUSCLE; URINALYSIS;

EID: 33847248903     PISSN: 09536205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejim.2006.09.020     Document Type: Review

References (75)

1. Knochel J.P. Mechanisms of rhabdomyolysis. Curr Opin Rheumatol 5 (1993) 725-731
2. Poels P.J.E., and Gabreels F.J.M. Rhabdomyolysis: a review of the literature. Clin Neurol Neurosurg 95 (1993) 175-192
3. Zager R.A. Rhabdomyolysis and myohemoglobinuric acute renal failure. Kidney Int 49 (1996) 314-326
4. Larbi E.B. Drug induced rhabdomyolysis: case report. East Afr Med J 74 (1997) 829-831
5. Vanholder R., Sever M.S., Erek E., and Lameire N. Rhabdomyolysis. J Am Soc Nephrol 11 (2000) 1553-1556
6. Beetham R. Biochemical investigation of suspected rhabdomyolysis. Ann Clin Biochem 37 (2000) 581-587
7. Holt S.G., and Moore K.P. Pathogenesis and treatment of renal dysfunction in rhabdomyolysis. Intens Care Med 27 (2001) 803-811
8. Holt S., and Moore K. Pathogenesis of renal failure in rhabdomyolysis: the role of myoglobin. Exp Nephrol 8 (2000) 72-76
9. Allison R.C., and Bedsole D.L. The other medical causes of rhabdomyolysis. Am J Med Sci 326 (2003) 79-88
10. Lindner A., and Zierz S. Rhabdomyolysis and myoglobinuria. Nervenarzt 74 (2003) 505-515
11. Polderman K.H. Acute renal failure and rhabdomyolysis. Int J Artif Organs 27 (2004) 1030-1033
12. Melli G., Chaudhry V., and Cornblath D.R. Rhabdomyolysis: an evaluation of 475 hospitalized patients. Medicine (Baltimore) 84 (2005) 377-385
13. Billis A.G., Kastanakis S., Giamarellou H., and Daikos G.K. Acute renal failure after a meal of quail. Lancet 2 (1971) 702
14. Bywaters E.G.L., and Beall D. Crush injuries with impairment of renal function. BMJ 1 (1941) 427-432
15. Guerini D., Coletto L., and Carafoli E. Exporting calcium from cells. Cell Calcium 38 (2005) 281-289
16. Carafoli E. Intracellular calcium homeostasis. Ánn Rev Biochem 56 (1987) 395-433
17. Green H.J. Cation pumps in skeletal muscle: potential role in muscle fatigue. Acta Physiol Scand 162 (1998) 201-213
18. Moller J.V., Nissen P., Sorensen T.L., and le Maire M. Transport mechanism of the sarcoplasmic reticulum Ca2+-ATPase pump. Curr Opin Struct Biol 15 (2005) 387-393
19. Clausen T. Na+-K+pump regulation and skeletal muscle contractility. Physiol Rev 83 (2003) 1269-1324
20. Knochel J.P. Neuromuscular manifestations of electrolyte disorders. Am J Med 72 (1982) 521-535
21. Pfeiffer D.R., Gunter T.E., Eliseev R., Broekemeier K.M., and Gunter K.K. Release of Ca2+ from mitochondria via the saturable mechanisms and the permeability transition. IUBMB Life 52 (2001) 205-212
22. Campanella M., Pinton P., and Rizzuto R. Mitochondrial Ca2+ homeostasis in health and disease. Biol Res 37 (2004) 653-660
23. Turrens J.F., Beconi M., Barilla J., Chavez U.B., and McCord J.M. Mitochondrial generation of oxygen radicals during reoxygenation of ischemic tissues. Free Radic Res Commun 12-13 (1991) 681-689
24. Warren J.D., Blumbergs P.C., and Thompson P.D. Rhabdomyolysis: a review. Muscle Nerve 25 (2002) 332-347
25. Stark G. Functional consequences of oxidative membrane damage. J Membr Biol 205 (2005) 1-16
26. ++ concentration during exertional rhabdomyolysis. Lancet 345 (1995) 424-425
27. Wrogemann K., and Pena S.D.J. Mitochondrial calcium overload: a general mechanism for cell-necrosis in muscle diseases. Lancet 1 (1976) 672-674
28. Rizzuto R., Pinton P., Ferrari D., Chami M., Szabadkai G., Magalhaes P.J., et al. Calcium and apoptosis: facts and hypotheses. Oncogene 22 (2003) 8619-8627
29. Gordon N. Glycogenosis type V or McArdle's disease. Dev Med Child Neurol 45 (2003) 640-644
30. Dimaur S., Andreu A.L., Bruno C., and Hadjigeorgiou G.M. Myophosphorylase deficiency (glycogenosis type V; McArdle disease). Curr Mol Med 2 (2002) 189-196
31. Gabow P.A., Kaehny W.D., and Kelleher S.P. The spectrum of rhabdomyolysis. Medicine 61 (1982) 141-153
32. Prendergast B.D., and George C.F. Drug-induced rhabdomyolysis - mechanisms and management. Postgrad Med J 69 (1993) 333-336
33. Bolton C.F. Neuromuscular manifestations of critical illness. Muscle Nerve 32 (2005) 140-163
34. Blanco J.R., Zabalza M., Salcedo J., and San Román J. Rhabdomyolysis as a result of Streptococcus pneumoniae: report of a case and review. Clin Microbiol Infect 9 (2003) 944-948
35. Singh D., Chander V., and Chopra K. Rhabdomyolysis. Methods Find Exp Clin Pharmacol 27 (2005) 39-48
36. Ali S.Z., Taguchi A., and Rosenberg H. Malignant hyperthermia. Best Pract Res Clin Anaesthesiol 17 (2003) 519-533
37. Wedel D.J. Malignant hyperthermia and neuromuscular disease. Neuromuscul Disord 2 (1992) 157-164
38. Thompson P.D., Clarkson P., and Karas R.H. Statin-associated myopathy. JAMA 289 (2003) 1681-1690
39. Guis S., Mattei J.P., and Liote F. Drug-induced and toxic myopathies. Best Pract Res Clin Rheumatol 17 (2003) 877-907
40. Allen D.G. Skeletal muscle function: role of ionic changes in fatigue, damage and disease. Clin Exp Pharmacol Physiol 31 (2004) 485-493
41. Nohl H., Gille L., and Staniek K. Intracellular generation of reactive oxygen species by mitochondria. Biochem Pharmacol 69 (2005) 719-723
42. Moopanar T.R., and Allen D.G. Reactive oxygen species reduce myofibrillar Ca2+ sensitivity in fatiguing mouse skeletal muscle at 37 degrees C. J Physiol 564 (2005) 189-199
43. Smith M.A., and Reid M.B. Redox modulation of contractile function in respiratory and limb skeletal muscle. Respir Physiol Neurobiol 151(2-3) (Apr 28 2006) 229-241
44. Vernon L.P., and Bell J.D. Membrane structure, toxins and phospholipase A2 activity. Pharmacol Ther 54 (1992) 269-295
45. Nigam S., and Schewe T. Phospholipase A(2)s and lipid peroxidation. Biochim Biophys Acta 1488 (2000) 167-181
46. Gommans I.M., Vlak M.H., de Haan A., and van Engelen B.G. Calcium regulation and muscle disease. J Muscle Res Cell Motil 23 (2002) 59-63
47. Brookes P.S., Yoon Y., Robotham J.L., Anders M.W., and Sheu S.S. Calcium, ATP, and ROS: a mitochondrial love-hate triangle. Am J Physiol Cell Physiol 287 (2004) C817-C833
48. Cadenas E. Biochemistry of oxygen toxicity. Ann Rev Biochem 58 (1989) 79-110
49. Cooper C.E., Vollaard N.B., Choueiri T., and Wilson M.T. Exercise, free radicals and oxidative stress. Biochem Soc Trans 30 (2002) 280-285
50. Brookes P.S. Mitochondrial H(+) leak and ROS generation: an odd couple. Free Radic Biol Med 38 (2005) 12-23
51. Galli F., Piroddi M., Annetti C., Aisa C., Floridi E., and Floridi A. Oxidative stress and reactive oxygen species. Contrib Nephrol 149 (2005) 240-260
52. DiMauro S., Tanji K., Bonilla E., Pallotti F., and Schon E.A. Mitochondrial abnormalities in muscle and other aging cells: classification, causes, and effects. Muscle Nerve 26 (2002) 597-607
53. Jezek P., and Hlavata L. Mitochondria in homeostasis of reactive oxygen species in cell, tissues, and organism. Int J Biochem Cell Biol 37 (2005) 2478-2503
54. Touyz R.M. Reactive oxygen species as mediators of calcium signaling by angiotensin II: implications in vascular physiology and pathophysiology. Antioxid Redox Signal 7 (2005) 1302-1314
55. Scheffler I.E. A century of mitochondrial research: achievements and perspectives. Mitochondrion 1 (2001) 3-31
56. 2+ increase and cell damage in L6 rat myoblasts by HMG-CoA reductase inhibitors. Biochem Biophys Res Commun 202 (1994) 1579-1585
57. Le Bras M., Clement M.V., Pervaiz S., and Brenner C. Reactive oxygen species and the mitochondrial signaling pathway of cell death. Histol Histopathol 20 (2005) 205-219
58. 2+ in cell physiology and pathophysiology. Cell Calcium 28 (2000) 339-348
59. Evans M.D., Dizdaroglu M., and Cooke M.S. Oxidative DNA damage and disease: induction, repair and significance. Mutat Res 567 (2004) 1-61
60. Juranek I., and Bezek S. Controversy of free radical hypothesis: reactive oxygen species - cause or consequence of tissue injury?. Gen Physiol Biophys 24 (2005) 263-278
61. Kantrow S.P., and Piantadosi C.A. Release of cytochrome c from liver mitochondria during permeability transition. Biochem Biophys Res Commun 232 (1997) 669-671
62. Zamzami N., Hirsch T., Dallaporta B., Petit P.X., and Kroemer G. Mitochondrial implication in accidental and programmed cell death: apoptosis and necrosis. J Bioenerg Biomembr 29 (1997) 185-193
63. Wardle E.N. Cellular oxidative processes in relation to renal disease. Am J Nephrol 25 (2005) 13-22
64. Malinoski D.J., Slater M.S., and Mullins R.J. Crush injury and rhabdomyolysis. Crit Care Clin 20 (2004) 171-192
65. Criddle L.M. Rhabdomyolysis: pathophysiology, recognition and management. Crit Care Nurse 23 (2003) 14-22
66. Koffler A., Friedler R.M., and Massry S.G. Acute renal failure due to nontraumatic rhabdomyolysis. Ann Intern Med 85 (1976) 23-28
67. Knochel J.P. Pigment nephropathy. In: Greenberg A. (Ed). Primer on kidney diseases (1998), Academic Press, Boston 273-276
68. Köppel C. Clinical features, pathogenesis and management of drug-induced rhabdomyolysis. Med Toxicol Adverse Drug Exp 4 (1989) 108-126
69. Rusell T.A. Acute renal failure related to rhabdomyolysis: pathophysiology, diagnosis and collaborative management. Nephrol Nurs J 27 (2000) 567-575
70. Schlattner U., Tokarska-Schlattner M., and Wallimann T. Mitochondrial creatine kinase in human health and disease. Biochim Biophys Acta 1762 (2006) 164-180
71. Kasper C.E., Talbot L.A., and Gaines J.M. Skeletal muscle damage and recovery. AACN Clin Issues 13 (2002) 237-247
72. Ward M.M. Factors predictive of acute renal failure in rhabdomyolysis. Arch Intern Med 148 (1988) 1553-1557
73. Berner Y.N., and Shike M. Consequences of phosphate imbalance. Annu Rev Nutr 8 (1988) 121-148
74. Meneghini L.F., Oster J.R., Camacho J.R., Gkonos P.J., and Roos B.A. Hypercalcemia in association with acute renal failure and rhabdomyolysis. case report and literature review. Miner Electrolyte Metab 19 (1993) 1-16
75. Llach F., Felsenfeld A.J., and Haussler M.R. The pathophysiology of altered calcium metabolism in rhabdomyolysis-induced acute renal failure. Interactions of parathyroid hormone, 25-hydroxycholecalciferol, and 1,25-dihydroxycholecalciferol. N Engl J Med 305 (1981) 117-123